Morepen Laboratories Ltd. — Investor Relations & Filings
Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Newspaper Publication- Q4 and FY 26 Financial Results | 2026-05-27 | English | |
| Copy of Newspaper Publication | 2026-05-27 | English | |
| Please find enclosed Investor Presentation on Q4 & FY26 Results | 2026-05-27 | English | |
| Please find enclosed press release | 2026-05-27 | English | |
| Press Release | 2026-05-27 | English | |
| Investor Presentation | 2026-05-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47226253 | Newspaper Publication- Q4 and FY 26 Financial Results | 2026-05-27 | English | ||
| 47199060 | Copy of Newspaper Publication | 2026-05-27 | English | ||
| 47098765 | Please find enclosed Investor Presentation on Q4 & FY26 Results | 2026-05-27 | English | ||
| 47098769 | Please find enclosed press release | 2026-05-27 | English | ||
| 47099100 | Press Release | 2026-05-27 | English | ||
| 47099097 | Investor Presentation | 2026-05-27 | English | ||
| 47062681 | Re-appointment of Cost Auditors of the Company | 2026-05-26 | English | ||
| 47061631 | Please find attached the file | 2026-05-26 | English | ||
| 47061666 | Please find attached the file | 2026-05-26 | English | ||
| 47061721 | Please find attached the file | 2026-05-26 | English | ||
| 47061729 | Appointment | 2026-05-26 | English | ||
| 47061726 | Dividend | 2026-05-26 | English | ||
| 47061722 | Outcome of Board Meeting | 2026-05-26 | English | ||
| 47061719 | Amendment(s) | 2026-05-26 | English | ||
| 47061814 | Please find attached outcome of Board meeting | 2026-05-26 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CS Medica A/S
Develops and manufactures OTC medical devices and cosmetics…
|
CSMED | DK | Manufacturing |
|
CSPC Innovation Pharmaceutical Co.,Ltd.
Global supplier of caffeine, pharmaceutical ingredients, an…
|
300765 | CN | Manufacturing |
|
CSPC Pharmaceutical Group Limited
R&D, manufacturing, and sale of innovative finished and bul…
|
1093 | HK | Manufacturing |
|
CStone Pharmaceuticals
Innovation-driven biopharma focused on R&D and commercializ…
|
2616 | KY | Manufacturing |
|
CTC BIO, INC.
Develops and manufactures human and animal health products …
|
060590 | KR | Manufacturing |
|
Cue Biopharma, Inc.
Develops biologics to selectively modulate the immune syste…
|
CUE | US | Manufacturing |
|
Cullinan Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
CGEM | US | Manufacturing |
|
CUMBERLAND PHARMACEUTICALS INC
Acquires, develops, and commercializes branded drugs for ho…
|
CPIX | US | Manufacturing |
|
Cuorips Inc.
Develops iPS cell-derived therapies and provides cell proce…
|
4894 | JP | Manufacturing |
|
Cuprina Holdings (Cayman) LTD
Biomedical firm developing wound care biotherapy and cosmec…
|
CUPR | US | Manufacturing |
Morepen Laboratories Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/59389/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=59389 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=59389 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=59389 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 59389}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Morepen Laboratories Ltd. (id: 59389)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.